⏳ Fetching live dividend data...
Home › Calculator › MBIO Dividend Calculator 2026
Mustang Bio, Inc. · NASDAQ
Price: $0.63 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in MBIO → $15673.50M in 10 years · $992,458,402.44/month
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-107 and MB-207, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-102 CAR T therapies for blastic plasmacytoid dendritic cell neoplasm, acute myeloid leukemia, and myelodysplastic syndrome; MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-104 CAR T for multiple myeloma and light chain amyloidosis; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clin Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH, and Minaris Regenerative Medicine GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MBIO position with:
Real after-tax yield depends on where you live and how you hold MBIO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 316.41% | 313.61% | $31,641 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 268.95% | 266.15% | $26,895 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 253.13% | 250.33% | $25,313 / yr |
| 🇬🇧 UK ISA | 0% | 316.41% | 313.61% | $31,641 / yr |
| 🇬🇧 UK Taxable | 8.75% | 288.72% | 285.92% | $28,872 / yr |
| 🇨🇦 TFSA | 0% | 316.41% | 313.61% | $31,641 / yr |
| 🇨🇦 CA Taxable | 25% | 237.31% | 234.51% | $23,731 / yr |
| 🇦🇺 Super (pension) | 15% | 268.95% | 266.15% | $26,895 / yr |
| 🇦🇺 AU Taxable | 30% | 221.49% | 218.69% | $22,149 / yr |
| 🇩🇪 DE Taxable | 26.375% | 232.96% | 230.16% | $23,296 / yr |
| 🇫🇷 FR Taxable | 30% | 221.49% | 218.69% | $22,149 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
MBIO pays quarterly — 4 times per year. Next ex-div: TBD.
How MBIO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MBIO sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-04-24 | 19 | $0.75 | $14.00 | ||
| A-Award | 2026-01-02 | 278,385 | — | — | ||
| Sale | 2025-12-30 | 247 | $0.96 | $238.00 | ||
| Sale | 2025-12-30 | 4 | $0.95 | $4.00 | ||
| Buy | 2025-12-30 | 247 | $0.96 | $238.00 | ||
| A-Award | 2025-09-29 | 59,334 | — | — | ||
| F-InKind | 2025-04-24 | 27 | $1.24 | $33.00 | ||
| A-Award | 2025-03-31 | 67,806 | — | — | ||
| A-Award | 2024-06-27 | 575,191 | — | — | ||
| F-InKind | 2024-05-31 | 1,396 | $0.35 | $489.00 |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MBIO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →